The DOI matches its Crossref record; 121 of the 123 references it cites were found in a registry or an index.
Understanding the Molecular Genetics of Basal Cell Carcinoma
Open accessAbstract
Basal cell carcinoma (BCC) is the most common human cancer and represents a growing public health care problem. Several tumor suppressor genes and proto-oncogenes have been implicated in BCC pathogenesis, including the key components of the Hedgehog pathway, PTCH1 and SMO, the TP53 tumor suppressor, and members of the RAS proto-oncogene family. Aberrant activation of the Hedgehog pathway represents the molecular driver in basal cell carcinoma pathogenesis, with the majority of BCCs carrying somatic point mutations, mainly ultraviolet (UV)-induced, and/or copy-loss of heterozygosis in the PTCH1 gene. Recent advances in sequencing technology allowed genome-scale approaches to mutation discovery, identifying new genes and pathways potentially involved in BCC carcinogenesis. Mutational and functional analysis suggested PTPN14 and LATS1, both effectors of the Hippo–YAP pathway, and MYCN as new BCC-associated genes. In addition, emerging reports identified frequent non-coding mutations within the regulatory promoter sequences of the TERT and DPH3-OXNAD1 genes. Thus, it is clear that a more complex genetic network of cancer-associated genes than previously hypothesized is involved in BCC carcinogenesis, with a potential impact on the development of new molecular targeted therapies. This article reviews established knowledge and new hypotheses regarding the molecular genetics of BCC pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overexposure to sunlight is directly connected the with onset of skin cancers such as basal cell carcinoma (BSC) [165], squamous cell carcinoma (SCC) [166,167], and malignant melanoma (MM) [168,169].”
From Focus on UV-Induced DNA Damage and Repair—Disease Relevance and Protective Strategies (2020) · cites this paper as [165]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vořechovský, I., Holmberg, E., Undén, A. B., Gillies, S. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,018
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A., Myers, R., Cox, D., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,856
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
The mechanisms of Hedgehog signalling and its roles in development and disease
Briscoe, J., & Thérond, P. P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3598 · Cited by 1,751
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
Patched1 Regulates Hedgehog Signaling at the Primary Cilium
Rohatgi, R., Milenkovic, L., & Scott, M. P. (2007) · Science · doi:10.1126/science.1139740 · Cited by 1,426
Activating Smoothened mutations in sporadic basal-cell carcinoma
Xie, J., Murone, M., Luoh, S.-M., Ryan, A. M., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C.-W., Hynes, M., Goddard, A. D., et al. (1998) · Nature · doi:10.1038/34201 · Cited by 1,333
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionPreprint
Zhao, B., Li, L., Lei, Q., & Guan, K. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,173
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Multiple Nevoid Basal-Cell Epithelioma, Jaw Cysts and Bifid Rib
Gorlin, R. J., & Goltz, R. W. (1960) · New England Journal of Medicine · doi:10.1056/nejm196005052621803 · Cited by 1,032
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 942
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 893
Basal cell carcinomas: attack of the hedgehog
Epstein, E. H. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2503 · Cited by 843
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K. J., Rashidi, B., & Yang, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 802
Rubin, A. I., Chen, E. H., & Ratner, D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044151 · Cited by 772
The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas
Gailani, M. R., Ståhle‐Bäckdahl, M., Leffell, D. J., Glyn, M., Zaphiropoulos, P. G., Undén, A. B., Dean, M. C., Brash, D. E., Bale, A. E., & Toftgård, R. (1996) · Nature Genetics · doi:10.1038/ng0996-78 · Cited by 763
Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.
Ziegler, A., Leffell, D. J., Kunala, S., Sharma, H. W., Gailani, M. R., Simon, J. A., Halperin, A. J., Baden, H. P., Shapiro, P. E., & Bale, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4216 · Cited by 739
Primary Cilia and Mammalian Hedgehog Signaling
Bangs, F., & Anderson, K. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028175 · Cited by 642
Dahmane, N., Lee, J. D., Robins, P., Heller, P., & Altaba, A. R. I. (1997) · Nature · doi:10.1038/39918 · Cited by 639
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
Rimkus, T. K., Carpenter, R. L., Qasem, S. A., Chan, M. D., & Lo, H. (2016) · Cancers · doi:10.3390/cancers8020022 · Cited by 580
Buonamici, S., Williams, J. A., Morrissey, M., Wang, A., Guo, R., Vattay, A., Hsiao, K., Yuan, J., Green, J., Ospina, B., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001599 · Cited by 562
The Mechanisms of UV Mutagenesis
Ikehata, H., & Ono, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.10175 · Cited by 542
Katoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Bonilla, X., Parmentier, L., King, B., Bezrukov, F., Kaya, G., Zoete, V., Seplyarskiy, V. B., Sharpe, H. J., McKee, T., Letourneau, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3525 · Cited by 491
Genome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484
Couzens, A. L., Knight, J. D. R., Kean, M. J., Teo, G., Weiss, A., Dunham, W. H., Lin, Z., Bagshaw, R. D., Sicheri, F., Pawson, T. J., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004712 · Cited by 456
Developmental defects in gorlin syndrome related to a putative tumor suppressor gene on chromosome 9
Gailani, M. R., Bale, S. J., Leffell, D. J., DiGiovanna, J. J., Peck, G. L., Poliak, S., Drum, M. A., Pastakia, B., McBride, O. W., Kase, R. G., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90122-s · Cited by 423
Zhang, H., Pasolli, H. A., & Fuchs, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019603108 · Cited by 419
Somatic mutations in thePTCH,SMOH,SUFUHandTP53genes in sporadic basal cell carcinomas
REIFENBERGER, J., Wolter, M., Knobbe-Thomsen, C. B., Köhler, B., Schönicke, A., Scharwächter, C., Kumar, K., Blaschke, B., Ruzicka, T., & Reifenberger, G. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06353.x · Cited by 392
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, H. J., Pau, G., Dijkgraaf, G. J. P., Basset‐Séguin, N., Modrusan, Z. D., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.001 · Cited by 382
Ultraviolet radiation and skin cancer: molecular mechanisms
Hussein, M. R. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00281.x · Cited by 356
Tumor-Suppressor Functions of the TP53 PathwayPreprint
Aubrey, B. J., Strasser, A., & Kelly, G. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026062 · Cited by 352
Non-melanoma skin cancer: what drives tumor development and progression?
Boukamp, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi123 · Cited by 346
Rachakonda, P. S., Hosen, M. I., de Verdier, P. J., Fallah, M., Heidenreich, B., Ryk, C., Wiklund, P. N., Steineck, G., Schadendorf, D., Hemminki, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310522110 · Cited by 343
Aszterbaum, M., Rothman, A., Fisher, M. P., Xie, J., Bonifas, J. M., Zhang, X., Epstein, E. H., Johnson, R. L., & Scott, M. P. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00222.x · Cited by 306
TP53 mutations in human skin cancers
Giglia‐Mari, G., & Sarasin, A. R. (2003) · Human Mutation · doi:10.1002/humu.10179 · Cited by 298
Slow Repair of Pyrimidine Dimers at p53 Mutation Hotspots in Skin Cancer
Tornaletti, S., & Pfeifer, G. P. (1994) · Science · doi:10.1126/science.8128225 · Cited by 296
Fredriksson, N. J., Ny, L., Nilsson, J. A., & Larsson, E. (2014) · Nature Genetics · doi:10.1038/ng.3141 · Cited by 295
Ras gene mutation and amplification in human nonmelanoma skin cancers
Pierceall, W. E., Goldberg, L. H., Tainsky, M. A., Mukhopadhyay, T., & Ananthaswamy, H. N. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040306 · Cited by 275
Epidemiology of basal cell carcinoma: scholarly review
Verkouteren, J., Ramdas, K., Wakkee, M., & Nijsten, T. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15321 · Cited by 254
Basset‐Séguin, N., Hauschild, A., Grob, J., Kunstfeld, R., Dréno, B., Mortier, L., Ascierto, P. A., Licitra, L. F., Dutriaux, C., Thomas, L., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70198-1 · Cited by 244
TERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238
A GLI1‐p53 inhibitory loop controls neural stem cell and tumour cell numbers
Stecca, B. A., & Altaba, A. R. I. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.16 · Cited by 236
Basal Cell Carcinomas Arise from Hair Follicle Stem Cells in Ptch1+/− Mice
Wang, G., Wang, J., Mancianti, M., & Epstein, E. H. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.007 · Cited by 233
Mutational Landscape of Basal Cell Carcinomas by Whole-Exome Sequencing
Jayaraman, S. S., Rayhan, D. J., Hazany, S., & Kolodney, M. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.276 · Cited by 225
p53 and the pathogenesis of skin cancer
Benjamin, C. L., & Ananthaswamy, H. N. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.006 · Cited by 223
Brodowska, K., Al-Moujahed, A., Marmalidou, A., Meyer zu Horste, M., Cichy, J., Miller, J. W., Gragoudas, E., & Vavvas, D. G. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.04.011 · Cited by 220
Smyth, I. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.291 · Cited by 213
p53 mutations in basal cell carcinomas.
Rady, P. L., Scinicariello, F., Wagner, R. F., & Tyring, S. K. (1992) · PubMed · Cited by 209
Relationship Between Sunlight Exposure and a Key Genetic Alteration in Basal Cell Carcinoma
Gailani, M. R., Leffell, D. J., Ziegler, A., Gross, E. G., Brash, D. E., & Bale, A. E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.6.349 · Cited by 206
TERT promoter mutations in telomere biology
Heidenreich, B., & Kumar, R. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.11.002 · Cited by 205
PTPN14 is required for the density-dependent control of YAP1
Wang, W., Huang, J., Wang, X., Yuan, J., Li, X., Feng, L., Park, J.-I., & Chen, J. (2012) · Genes & Development · doi:10.1101/gad.192955.112 · Cited by 195
Ramaswamy, B., Lu, Y., Teng, K., Nuovo, G. J., Li, X., Shapiro, C. L., & Majumder, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1248 · Cited by 195
Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
Gonnissen, A., Isebaert, S. F., & Haustermans, K. M. (2015) · Oncotarget · doi:10.18632/oncotarget.4224 · Cited by 181
Ras Oncogene Mutations in Basal Cell Carcinomas and Squamous Cell Carcinomas of Human Skin
van der Schroeff, J. G., Evers, L. M., Boot, A. J. M., & Bos, J. L. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874504 · Cited by 179
Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
Jimeno, A., Weiss, G. J., Miller, W. H., Gettinger, S. N., Eigl, B. J., Chang, A. L. S., Dunbar, J., Devens, S., Faia, K., Skliris, G. P., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3654 · Cited by 171
Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms
Lacour, J. ‐. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.146.s61.5.x · Cited by 168
Teh, M., Blaydon, D. C., Chaplin, T., Foot, N. J., Skoulakis, S., Raghavan, M., Harwood, C. A., Proby, C. M., Philpott, M. P., Young, B. D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0842 · Cited by 159
Trends in Basal Cell Carcinoma Incidence Rates: A 37-Year Dutch Observational Study
Flohil, S. C., Seubring, I., van Rossum, M. M., Coebergh, J. W. W., de Vries, E., & Nijsten, T. E. C. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.431 · Cited by 157
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Pricl, S., Cortelazzi, B., Col, V. D., Marson, D., Laurini, E., Fermeglia, M., Licitra, L. F., Pilotti, S., Bossi, P., & Perrone, F. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.003 · Cited by 155
Hatton, B. A., Knoepfler, P. S., Kenney, A. M., Rowitch, D. H., de Alborán, I. M., Olson, J. M., & Eisenman, R. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1621 · Cited by 154
Sonic hedgehog signaling in basal cell carcinomas
Daya–Grosjean, L., & Couvé, S. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.003 · Cited by 153
Falchook, G. S., Leidner, R. S., Stankevich, E., Piening, B., Bifulco, C. B., Lowy, I., & Fury, M. G. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0176-3 · Cited by 152
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Lipson, E. J., Lilo, M. T., Ogurtsova, A., Esandrio, J., Xu, H., Brothers, P., Schollenberger, M. D., Sharfman, W. H., & Taube, J. M. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0228-3 · Cited by 147
Human Basal Cell Carcinoma Is Associated with Foxp3+ T cells in a Th2 Dominant Microenvironment
Kaporis, H. G., Guttman‐Yassky, E., Lowes, M. A., Haider, A. S., Fuentes‐Duculan, J., Darabi, K., Whynot, J. A., Khatcherian, A., Cardinale, I. R., Novitskaya, I., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700884 · Cited by 139
Justilien, V., & Fields, A. P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0507 · Cited by 131
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov, S. V., Walker, C. M., Strom, S. S., Selvan, M. S., Clayman, G. L., El‐Naggar, A. K., Lippman, S. M., Kripke, M. L., & Ananthaswamy, H. N. (2003) · PubMed · Cited by 130
TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
Pópulo, H., Boaventura, P., Vinagre, J., Batısta, R., Mendes, A., Caldas, R., Pardal, J., Azevedo, F., Honavar, M., Guimarães, I., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.163 · Cited by 129
Sheng, T., Chi, S., Zhang, X., & Xie, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500300200 · Cited by 125
Seto, M., Ohta, M., Asaoka, Y., Ikenoue, T., Tada, M., Miyabayashi, K., Mohri, D., Tanaka, Y., Ijichi, H., Tateishi, K., et al. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20516 · Cited by 123
Sonic Hedgehog Signaling in Basal Cell Nevus Syndrome
Athar, M., Li, C., Kim, A. L., Spiegelman, V. S., & Bickers, D. R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1666 · Cited by 123
Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond
Bakshi, A., Chaudhary, S. C., Rana, M., Elmets, C. A., & Athar, M. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22690 · Cited by 122
The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis
Rajurkar, M., DeJesus-Monge, W. E., Driscoll, D. R., Appleman, V. A., Huang, H., Cotton, J. L., Klimstra, D., Zhu, L., Simin, K., Xu, L., et al. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1114168109 · Cited by 119
Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias
Kim, M. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(01)00170-0 · Cited by 116 · cited 1×
“About half of these mutations contains the “UV-signature” C-T and tandem CC-TT transitions [17–19,22,48,51,53]; however, the UV radiation origin of PTCH1 mutations is controversial, since other factors, such as oxidative stress, have been implicated in the mutagenesis of this gene [12,18,22,54].”
BackgroundMutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma
SCOTT, G. A., Laughlin, T. S., & Rothberg, P. G. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.167 · Cited by 109
Role of PTCH and p53 Genes in Early-Onset Basal Cell Carcinoma
Zhang, H., Ping, X. L., Lee, P. K., Wu, X. L., Yao, Y. J., Zhang, M. J., Silvers, D. N., Ratner, D., Malhotra, R., Peacocke, M., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63980-6 · Cited by 108
Management of high-risk and advanced basal cell carcinoma
Puig, S., & Berrocal, A. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1272-9 · Cited by 107
Zhou, J., Zhu, G., Huang, J. X., Li, L., Du, Y., Gao, Y., Wu, D., Wang, X., Hsieh, J., He, D., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.006 · Cited by 104
TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
Heidenreich, B., Rachakonda, P. S., Hosen, M. I., Volz, F., Hemminki, K., Weyerbrock, A., & Kumar, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3329 · Cited by 101
Interleukin‐17 and interleukin‐22 promote tumor progression in human nonmelanoma skin cancer
Nardinocchi, L., Sonego, G., Passarelli, F., Avitabile, S., Scarponi, C., Failla, C. M., Simoni, S., Albanesi, C., & Cavani, A. (2014) · European Journal of Immunology · doi:10.1002/eji.201445052 · Cited by 99
TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
Griewank, K., Murali, R., Schilling, B., Schimming, T. T., Möller, I., Moll, I., Schwamborn, M., Sucker, A., Zimmer, L., Schadendorf, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080354 · Cited by 97
The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity
Michaloglou, C., Lehmann, W., Martin, T., Delaunay, C., Hueber, A., Barys, L., Niu, H., Billy, É., Wartmann, M., Ito, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061916 · Cited by 94
Wilson, K. E., Li, Y.-W., Yang, N., Shen, H., Orillion, A. R., & Zhang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534701 · Cited by 92
Cytokine profiles in spontaneously regressing basal cell carcinomas
Wong, D. A., Bishop, G. A., Lowes, M. A., Cooke, B. E., Barnetson, R. S. C., & Halliday, G. M. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03596.x · Cited by 89
Zhang, K., Sun, C., Zhang, Q., & Xiaojing, W. (2014) · Medical Oncology · doi:10.1007/s12032-014-0368-y · Cited by 85
Hammond, D. E., Zeng, K., Espert, A., Bastos, R. N., Baron, R. D., Grüneberg, U., & Barr, F. A. (2013) · Journal of Cell Science · doi:10.1242/jcs.128397 · Cited by 79
Brinkhuizen, T., Reinders, M. G. H. C., van Geel, M., Hendriksen, A. J. L., Paulussen, A. D. C., Winnepenninckx, V. J. L., Keymeulen, K., Soetekouw, P. M. M. B., Steensel, M. A. M. V., & Mosterd, K. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.001 · Cited by 75
Genetics of basal cell carcinoma
de Zwaan, S. E., & Haass, N. K. (2009) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2009.00579.x · Cited by 74
Hedgehog signaling in basal cell carcinoma
Otsuka, A., Levesque, M. P., Dummer, R., & Kabashima, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.02.007 · Cited by 72
Daya–Grosjean, L., & Sarasin, A. R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00025-7 · Cited by 69
Frequent DPH3 promoter mutations in skin cancers
Denisova, E., Heidenreich, B., Nagore, E., Rachakonda, P. S., Hosen, M. I., Akrap, I., Traves, V., García‐Casado, Z., López‐Guerrero, J. A., Requena, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5771 · Cited by 68
A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
Wagner, A. J., Messersmith, W. A., Shaik, M. N., Li, S., Zheng, X., McLachlan, K. R., Cesari, R., Courtney, R., Levin, W. J., & El-Khoueiry, A. B. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1116 · Cited by 66
Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention
Deady, S., Sharp, L. A., & Comber, H. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12988 · Cited by 58
Yamamoto, J., Plaza, P., & Brettel, K. (2016) · Photochemistry and Photobiology · doi:10.1111/php.12696 · Cited by 57
Protein Phosphatase PP6 N Terminal Domain Restricts G1to S Phase Progression in Human Cancer Cells
Stefansson, B., & Brautigan, D. L. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4276 · Cited by 56
Hauschild, A., Eichstaedt, J., Möbus, L., Kähler, K. C., Weichenthal, M., Schwarz, T., & Weidinger, S. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.026 · Cited by 56
Deng, W., Vanderbilt, D. B., Lin, C., Martin, K. H., Brundage, K. M., & Ruppert, J. M. (2015) · Journal of Cell Science · doi:10.1242/jcs.162164 · Cited by 53
Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer
Tornaletti, S., & Pfeifer, G. P. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90251-8 · Cited by 49
Heitzer, E., Lassacher, A., Quehenberger, F., Kerl, H., & Wolf, P. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700923 · Cited by 41
Danaee, H., Karagas, M. R., Kelsey, K. T., Perry, A. E., & Nelson, H. H. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700209 · Cited by 39
Pellegrini, C., Orlandi, A., Costanza, G., Stefani, A. D., Piccioni, A., Cesare, A. D., Chiricozzi, A., Ferlosio, A., Peris, K., & Fargnoli, M. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183415 · Cited by 38
Self-citationDabestani, R., & Ivanov, I. N. (1999) · Photochemistry and Photobiology · doi:10.1562/0031-8655(1999)070 · Cited by 38
Makinodan, E., & Marneros, A. G. (2012) · Experimental Dermatology · doi:10.1111/exd.12016 · Cited by 33
Non-melanoma skin cancer: new and future synthetic drug treatments
Amaral, T. M. S., & Garbe, C. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1316372 · Cited by 30
Cytokine concentrations in basal cell carcinomas of different histological types and localization.
Elamin, I., Zečević, R. D., Vojvodić, D., Medenica, L., & Pavlović, M. D. (2008) · PubMed · Cited by 27
Atwood, S. X., Sarin, K. Y., Li, J., Yao, C., Urman, N. M., Chang, A. L. S., Tang, J. Y., & Oro, A. E. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.115 · Cited by 24
Silencing of Diphthamide Synthesis 3 (Dph3) Reduces Metastasis of Murine Melanoma
Wang, L., Shi, Y., Ju, P., Liu, R., Yeo, S. P., Xia, Y., Owlanj, H., & Feng, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049988 · Cited by 24
Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma
Freier, K., Flechtenmacher, C., Devens, F., Hartschuh, W., Hofele, C., Lichter, P., & Joos, S. (2006) · Oncology Reports · doi:10.3892/or.15.5.1141 · Cited by 21
Kish, T. D., & Corry, L. (2016) · PubMed · Cited by 18
Unique features of PTCH1 mutation spectrum in Chinese sporadic basal cell carcinoma
Huang, Y. S., Bu, D., Li, X. Y., Ma, Z., Yang, Y., Lin, Z. M., Lu, F., Tu, P., & Li, H. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04453.x · Cited by 15
Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions
Urman, N. M., Mirza, A., Atwood, S. X., Whitson, R. J., Sarin, K. Y., Tang, J. Y., & Oro, A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168031 · Cited by 14
Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma
Smaele, E. D., Cucchi, D., Occhione, M. A., & Gulino, A. (2012) · Journal of Experimental Pharmacology · doi:10.2147/jep.s28553 · Cited by 13
Dahmane, N., Lee, J., Robins, P., Heller, P., & Altaba, A. R. I. (1997) · Nature · doi:10.1038/37408 · Cited by 10
Frequency and features ofTP53mutation in 30 Chinese patients with sporadic basal cell carcinoma
Wang, Y. M., Huang, Y. S., H., Z., Bu, D., Wang, Y., Tu, P., & Li, H. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12411 · Cited by 9
Tumor Site Immune Markers Associated with Risk for Subsequent Basal Cell Carcinomas
Glaser, R., Andridge, R., Yang, E. V., Shana’ah, A. Y., Gregorio, M. D., Chen, M., Johnson, S. L., Renne, L. D., Lambert, D. R., Jewell, S. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025160 · Cited by 8
Tate, G., Kishimoto, K., & Mitsuya, T. (2014) · Medical Molecular Morphology · doi:10.1007/s00795-014-0086-8 · Cited by 7
Santos, D. C. C., Zaphiropoulos, P. G., Neto, C. F., Pimentel, E. R. D. A., Sanches, J. A., & Ruiz, I. R. G. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04866.x · Cited by 6
p53 Mutations in Basal Cell Carcinomas Arising in Routine Users of Sunscreens
Rosenstein, B. S., Phelps, R. G., Weinstock, M. A., et al. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb08285.x
Flagged first, then by citations
2 of the 123 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- White, 1894, Multiple benign cystic epitheliomas, J. Cutan. Genitourin. Dis., 12, 477
- Jarisch, 1894, On the doctrine of skin tumors, Arch. Dermatol. Syphilol., 18, 162
Cited by
Sorted by citations
Peris, K., Fargnoli, M. C., Garbe, C., Kaufmann, R., Bastholt, L., Basset‐Séguin, N., Bataille, V. A., del Mármol, V., Dummer, R., Harwood, C. A., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.06.003 · Cited by 600
Self-citationPeris, K., Fargnoli, M. C., Kaufmann, R., Arenberger, P., Bastholt, L., Basset‐Séguin, N., Bataille, V. A., Brochez, L., del Mármol, V., Dummer, R., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113254 · Cited by 354
Self-citationSkin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures
Khan, N. H., Mir, M., Qian, L., Baloch, M., Khan, M. F. A., Rehman, A. U., Ngowi, E. E., Wu, D., & Ji, X. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.014 · Cited by 254
The Pathobiology of Skin Aging
Russell-Goldman, E. E., & Murphy, G. F. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.03.007 · Cited by 224
Basal Cell Carcinoma: A Comprehensive Review
Dika, E., Scarfì, F., Ferracin, M., Broseghini, E., Marcelli, E., Bortolani, B., Campione, E., Riefolo, M., Ricci, C., & Lambertini, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155572 · Cited by 205
Metadata
- Authors
- Pellegrini, C., Maturo, M., Di Nardo, L., Ciciarelli, V., Gutiérrez García-Rodrigo, C., & Fargnoli, M.
- Affiliations
- University of L'Aquila (IT)
- Department of Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, Italy
- Corresponding author
- Fargnoli, Maria
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-11-22
- Volume
- 18
- Issue
- 11
- Pages
- 2485
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5713451
- OpenAlex
- W2770311193
- Cited by
- 242
- References
- 123
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 25 · 2023: 27 · 2022: 41 · 2021: 46 · 2020: 37 · 2019: 20 · 2018: 8
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Dermatology › Nonmelanoma Skin Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Dermatology › Cancer and Skin Lesions
- Keywords
- basal cell carcinoma, tumor suppressor, proto-oncogenes, Hedgehog signaling, PTCH1, SMO, TP53, Ras family, UV-induced mutations, PTPN14, LATS1, Hippo signaling pathway, MYCN, TERT promoter mutation, carcinogenesis, targeted therapy
- MeSH terms
- Proto-Oncogene Mas, Animals, Basal Cell Carcinoma, Cell Transformation, Neoplastic, Humans, Mutation, Skin Neoplasms, Genetic Therapy, Signal Transduction, Biomarkers, Gene Expression Regulation, Neoplastic, Loss of Heterozygosity, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
